Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low-impact fractures

Nursing and Health Professions

• Practice Guideline 100%
• Vitamin D 100%
• Teaching Hospital 50%
• Primary Prevention 50%
• Rehabilitation Center 50%
• Health Maintenance Organization 50%
• Emergency Ward 50%
• Secondary Prevention 50%
• Alendronic Acid 50%
• Fragility Fracture 50%
• Raloxifene 50%
• Orthopedic Surgery 50%
• Multivariate Analysis 50%
• Drug Utilization 50%

Keyphrases

• Management Guidelines 100%
• Anti-osteoporosis Drugs 100%
• Low-impact Fractures 100%
• Drug Dispensing 22%
• Israel 11%
• Hospitalization 11%
• Pharmacy 11%
• Dispensation 11%
• First Year 11%
• Primary Prevention 11%
• Vitamin D 11%
• Multivariate Analysis 11%
• Computerized Database 11%
• Health Maintenance Organizations 11%
• Age 50 11%
• National Health 11%
• Positive Impact 11%
• Newly Diagnosed 11%
• Orthopedic Surgery 11%
• Fold Increase 11%
• Osteoporosis 11%
• Secondary Prevention 11%
• Female Gender 11%
• Surgery Department 11%
• Emergency Room 11%
• Antiresorptive 11%
• Osteoporotic Fractures 11%
• Vitamin D Supplementation 11%
• Alendronate 11%
• Traumatic Impact 11%
• Raloxifene 11%
• Teaching Hospital 11%
• Osteoporosis Drugs 11%
• New Fracture 11%
• Fracture Rate 11%
• Drug Utilization 11%
• Rehabilitation Department 11%
• Pharmacological Interventions 11%
• Orthopedic Rehabilitation 11%
• Calcium/vitamin D 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Vitamin D 100%
• Alendronic Acid 50%
• Raloxifene 50%
• Fragility Fracture 50%
• Drug Utilization 50%